Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting
Recruiting
N/AInterventional Study
Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
12 – 60
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
20 (estimated)
Sponsor
Sohag University · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Split-thickness skin grafting (STSG) is one of the most commonly performed procedures to achieve wound closure. Most studies are concerned on improving the appearance of scars and shortening the healing time of the recipient sites. However, the management of the donor site usually takes a second consideration.
There is a lack of consensus on the recommended method of donor site management. Donor …
Split-thickness skin grafting (STSG) is one of the most commonly performed procedures to achieve wound closure. Most studies are concerned on improving the appearance of scars and shortening the healing time of the recipient sites. However, the management of the donor site usually takes a second consideration.
There is a lack of consensus on the recommended method of donor site management. Donor site morbidity of STSG is usually minimal, but that may not always be the case. Morbidity may include pigmentary abnormalities, prolonged pain and itching, delayed healing, or unfavorable scarring. So, an effort must be taken to find the optimal solution for donor site healing and minimize morbidity.
Small portions of the skin graft left at the end of the procedure or the graft pieces obtained after trimming the edges are usually discarded. There have been some studies demonstrating the benefit of the minced residual skin graft on the donor site, possibly resulting in earlier epithelialization and improving the appearance
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* All patients undergoing split-thickness skin grafting, between 12 - 60 years of age.
Exclusion Criteria:
* Patients under the age of 12 years or above 60 years.
* Patients with a known tendency for hypertrophic scarring/keloids
* Pregnancy
* Co-morbid factors such as uncontr…
Inclusion Criteria:
* All patients undergoing split-thickness skin grafting, between 12 - 60 years of age.
Exclusion Criteria:
* Patients under the age of 12 years or above 60 years.
* Patients with a known tendency for hypertrophic scarring/keloids
* Pregnancy
* Co-morbid factors such as uncontrolled diabetes, ischemic heart disease, renal failure or Collagen vascular disease.
Contacts
Mohamed Abd Elmawla Mohamed, Resident plastic surgeon
Gamal Yousef Elsayed, Professor of plastic surgery
+20 115 6996929
CONTACT
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.